DOCSLIB.ORG

Treating Epidermal Melasma with a 4% Hydroquinone Skin Care System Plus Tretinoin Cream 0.025%

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Treating Epidermal Melasma with a 4% Hydroquinone Skin Care System Plus Tretinoin Cream 0.025% TherapeuTics for The clinician Treating Epidermal Melasma With a 4% Hydroquinone Skin Care System Plus Tretinoin Cream 0.025% Pearl Grimes, MD; JoAnne Watson, DPM We sought to evaluate the efficacy and tolerability erythema, peeling, and stinging sensation). The of treating melasma using a 4% hydroquinone skin 4% hydroquinone skin care system plus tretinoin care system, including a proprietary cleanser, cream 0.025% is effective and well-tolerated in toner, 4% hydroquinone, exfoliation enhancer, and the treatment of melasma. sunscreen, plus tretinoin cream 0.025%. Together Cutis. 2013;91:47-54. these products offer not only treatment of melasma but also a complete skin care regimen. Twenty participants with mild or moderate epidermal elasma is symmetric facial hypermelanosis melasma with Fitzpatrick skin types III to VI were characterized by patches of light brown or instructed to use the hydroquinone skin care M gray-brown macules on sun-exposed skin. system and tretinoin cream CUTISfor 12 weeks. It occurs most commonly in women, especially those Melasma severity, melasma pigmentation living in areas of intense sunlight.1 The misconcep- intensity, and melasma area and severity tion that melasma is merely a cosmetic nuisance index (MASI) score were significantly reduced from has resulted in underdiagnosis and undertreatment.2 week 4 onward relative to baseline (P≤.01). The However, the condition can cause great distress proportion of participants who felt embarrassed or and can have substantial negative effects on the self-conscious about their skin very much or a lot emotional well-being, social life, and quality of life declinedDo from 80% (16/20) toNot 20% (4/20) between (QOL) Copyof patients.3 baseline and week 12. Similarly, the proportion of Several factors may be involved in triggering those who made very much or a lot of effort to hide melasma, including genetic influences, pregnancy, their skin discoloration declined from 90% (18/20) UV light, oral contraceptives, phototoxic drugs, and to 37% (7/19). In total, 85% (17/20) of participants antiseizure drugs.4 Because exposure to UV light were satisfied with the overall effectiveness of the appears to be one of the most important triggers,5 a study treatment. Three participants had adverse broad-spectrum sunscreen should always be part of events probably related to treatment (dryness, any depigmenting treatment regimen; its inclusion has been proven to enhance the effectiveness of treat- ment.6 Hydroquinone is the most effective topical Dr. Grimes is from the Vitiligo and Pigmentation Institute of bleaching agent approved by the US Food and Drug Southern California, Los Angeles. Dr. Watson is from the Clinical Administration for the treatment of melasma.4 It Affairs Department, OMP, Inc, Long Beach, California. reduces the synthesis of melanin by inhibiting tyrosi- This study was supported by OMP, Inc. Dr. Grimes has been an nase activity and also may be involved in the degra- investigator or consultant for Aclaris Therapeutics, Inc; Clinuvel 4 Pharmaceuticals; Combe Inc; Merz Pharmaceuticals; SkinMedica; dation of melanosomes and melanocytes. Tretinoin 5,7,8 and Suneva Medical, Inc. She also has been an investigator and also is effective in the treatment of melasma. consultant for OMP, Inc, and Procter & Gamble; an investigator and Tretinoin may enhance the penetration of hydroqui- speaker for Galderma Laboratories, LP; and an investigator, consul- none through the stratum corneum, protect hydroqui- tant, and speaker for Allergan, Inc. Dr. Watson is an employee of and none from oxidation, and facilitate pigment removal holds stock and stock options in OMP, Inc. 9 Correspondence: Pearl Grimes, MD, Vitiligo and Pigmentation by accelerating keratinocyte turnover. Institute of Southern California, 5670 Wilshire Blvd, Ste 650, Although both hydroquinone and tretinoin are Los Angeles, CA 90036 ([email protected]). effective in treating melasma,10-12 a disadvantage WWW.CUTIS.COM VOLUME 91, JANUARY 2013 47 Copyright Cutis 2013. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Therapeutics for the Clinician of monotherapy with either agent is the prolonged skin (eg, from UV light) or facial sunburn; anticipated treatment time required before meaningful results need to use other medicated products on the face are achieved. For example, it has been reported that during the study; excessive or prolonged exposure to it may take 24 weeks to achieve notable improve- sunlight without protective clothing; and pregnancy, ment with tretinoin treatment.8 With combination breastfeeding, or planning to become pregnant during therapy, meaningful improvements can be achieved the study. more rapidly. The following washout periods were required: We sought to evaluate the efficacy and tolerability 1 week for medicated facial cleansers and facial hair of treating melasma using a 4% hydroquinone skin removal procedures; 30 days for topical prescription care system plus tretinoin cream 0.025%, which not treatments, sunbathing and UV-light therapy, topical only treats melasma but also provides a complete skin medications, bleaching products, and photosensitiz- care regimen including protection from UV light. ing procedures or medications on the face includ- ing corticosteroids, hydroquinone, -hydroxy acids, Methods b-hydroxy acids, kojic acid, retinoic acid, retinol, Participants—Female patients were eligible to enroll salicylic acid, and vitamin C and vitamin D products in the study if they met the following inclusion or derivatives; 6 weeks for facial microdermabrasion; criteria: mild or moderate epidermal melasma, con- 12 weeks for systemic steroids; and 6 months for firmed with Wood lamp examination; minimal to photoallergic, phototoxic, and photosensitizing drugs marked intensity of melasma pigmentation; cutaneous or systemic retinoids, methotrexate, laser resurfacing melanosis that had been stable over the preceding procedures, deep skin peels, and injection of dermal 3 months; Fitzpatrick skin types III to VI; and aged fillers or botulinum toxin type A. 25 to 65 years. The study was conducted in accordance with the Participants were required to be willing to refrain 2004 version of the Declaration of Helsinki and all from the following throughout the study: facial use participants signed informed consent. The study was of nonstudy topical products including medications, performed between May 2010 and September 2010. moisturizers, sunscreens, fragrances, and medicated Treatment Regimen—Participants were instructed makeup, though oil-free noncomedogenicCUTIS makeup, to use the 4% hydroquinone skin care system plus mascara, eyeliner, eye shadow, and lipstick were tretinoin cream 0.025% on their entire face for allowed; facial procedures including chemical peels, 12 weeks. The 4% hydroquinone skin care system facial microdermabrasion, laser resurfacing, nonab- involved applying the following proprietary products: lative laser, light or radiofrequency treatment, and foaming gel cleanser (Nu-Derm® Foaming Gel), toner injection of dermal fillers or botulinum toxin type A; (Nu-Derm Toner), 4% hydroquinone (1 g)(Nu-Derm facial hair removal, except plucking of eyebrows with Clear), exfoliation enhancer containing -hydroxy tweezers,Do which was allowed; andNot use of systemic reti- acids (0.5Copy g)(Nu-Derm Exfoderm Forte), and sun- noids, methotrexate, photoallergic drugs, phototoxic screen (Nu-Derm Healthy Skin Sun Protection drugs, and photosensitizing drugs. Sunbathing, the use SPF 35)(all Nu-Derm products from OMP, Inc). The of tanning booths, and the facial use of tanning prod- cleanser, toner, and hydroquinone were applied twice ucts also were prohibited; participants were required daily, and the exfoliation enhancer and sunscreen to wear appropriate protective clothing when exposed were applied each morning. Tretinoin cream 0.025% to the sun. Participants taking oral contraceptives or (0.5 g) was mixed with 4% hydroquinone (0.5 g) hormonal replacement therapy were required not to (Nu-Derm Blender) and applied each evening. alter their treatment during the study. On the instruction of the investigator, participants Exclusion criteria included the following: his- could use a study moisturizer (Nu-Derm Action) for tory or presence of any facial skin condition that dryness or 0.5% hydrocortisone (Nu-Derm Tolereen) might interfere with diagnosis or evaluation during for other tolerability issues such as itching, erythema, the study; known hypersensitivity or allergy to sul- and irritation, as needed. This study was unblinded fites or ingredients in the study treatment products, and the investigator and participants were aware of including parabens and aloe; history of increased the treatment being given. pigmentation and/or contact dermatitis with prior Outcome Measures—The investigator evaluated use of hydroquinone or tretinoin; dermal melasma melasma severity, melasma pigmentation intensity, or a combination of dermal or epidermal melasma; melasma area and severity index (MASI) score, postinflammatory hyperpigmentation; vitiligo; history melasma improvement, erythema, dryness, peeling, or presence of Ota nevus; depressed or atrophic macu- and burning/stinging at baseline and/or weeks 4, 8, lar lesions; requirement for hormonal treatment that and 12 (Tables 1 and 2). Participants completed a might enhance pigmentation; irritation of exposed questionnaire13 at each time point asking them to 48 CUTIS® WWW.CUTIS.COM Copyright
Load more

Recommended publications
  • Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D
    Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department of Dermatology and Cutaneous Surgery What Determines Skin Color? What Determines Skin Color? No significant difference in the number of melanocytes between the races 2000 epidermal melanocytes/mm2 on head and forearm 1000 epidermal melanocytes/mm2 on the rest of the body differences present at birth Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff,K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192-220, New York, NY: McGraw Hill Melanosomes in Black and White Skin Black White Szabo G, Gerald AB, Pathak MA, Fitzpatrick TB. Nature1969;222:1081-1082 Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192- 220, New York, NY: McGraw Hill Role of Melanin-Advantages Melanin absorbs and scatters energy from UV and visible light to protect epidermal cells from UV damage Disadvantages Inflammation or injury to the skin is almost immediately accompanied by alteration in pigmentation Hyperpigmentation Hypopigmentation Dyschromias Post-Inflammatory hyperpigmentation Acne Melasma Lichen Planus Pigmentosus Progressive Macular Hypomelanosis
    [Show full text]
  • Common Breastfeeding Questions
    Common Breastfeeding Questions How often should my baby nurse? Your baby should nurse 8-12 times in 24 hours. Baby will tell you when he’s hungry by “rooting,” sucking on his hands or tongue, or starting to wake. Just respond to baby’s cues and latch baby on right away. Every mom and baby’s feeding patterns will be unique. Some babies routinely breastfeed every 2-3 hours around the clock, while others nurse more frequently while awake and sleep longer stretches in between feedings. The usual length of a breastfeeding session can be 10-15 minutes on each breast or 15-30 minutes on only one breast; just as long as the pattern is consistent. Is baby getting enough breastmilk? Look for these signs to be sure that your baby is getting enough breastmilk: Breastfeed 8-12 times each day, baby is sucking and swallowing while breastfeeding, baby has 3- 4 dirty diapers and 6-8 wet diapers each day, the baby is gaining 4-8 ounces a week after the first 2 weeks, baby seems content after feedings. If you still feel that your baby may not be getting enough milk, talk to your health care provider. How long should I breastfeed? The World Health Organization and the American Academy of Pediatrics recommends mothers to breastfeed for 12 months or longer. Breastmilk contains everything that a baby needs to develop for the first 6 months. Breastfeeding for at least the first 6 months is termed, “The Golden Standard.” Mothers can begin breastfeeding one hour after giving birth.
    [Show full text]
  • Dr. Hale's Lactation Risk Categories
    Just like during pregnancy, it is extremely important to talk to your doctor, pharmacist or lactation consultant before taking any medications. Most medications are safe, but there are many that can pass through your breastmilk to baby. Your lactation consultant also has access to resources about medication safety and breastfeeding. Medication Category Dr. Hale’s Lactation Risk Categories Acetaminophen (Tylenol) L1 L1 Safest Amoxicillin L1 Drug which has been taken by a large number of breastfeeding moth- ers without any observed increase in adverse effects in the infant. Aspirin L3 Controlled studies in breastfeeding women fail to demonstrate a risk to the infant and the possibility of harm to the breastfeeding infant is Birth Control – ONLY Acceptable remote; or the product is not orally bioavailable in an infant. L2 Safer Norethindrone, Depo-Provera, Drug which has been studied in a limited number of breastfeeding Implanon, Mirena, Plan B women without an increase in adverse effects in the infant; And/or, the evidence of a demonstrated risk which is likely to follow use of this medication in a breastfeeding woman is remote. Cetrizine (Zyrtec) L2 L3 Moderately Safe There are no controlled studies in breastfeeding women, however Dextromethorphan (Robitussin L1 the risk of untoward effects to a breastfed infant is possible; or, con- etc.) trolled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the poten- Dimenhydrinate (Dramamine) L2 tial risk to the infant. L4 Possibly Hazardous Diphenhydramine (Benadryl) L2 There is positive evidence of risk to a breastfed infant or to breast- milk production, but the benefits of use in breastfeeding mothers Fluoxetine (Prozac) L2 may be acceptable despite the risk to the infant (e.g.
    [Show full text]
  • Melasma (1 of 8)
    Melasma (1 of 8) 1 Patient presents w/ symmetric hyperpigmented macules, which can be confl uent or punctate suggestive of melasma 2 DIAGNOSIS No ALTERNATIVE Does clinical presentation DIAGNOSIS confirm melasma? Yes A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen B Pharmacological therapy Monotherapy • Hydroquinone or • Tretinoin TREATMENT Responding to No treatment? See next page Yes Continue treatment © MIMSas required Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B94 © MIMS 2019 Melasma (2 of 8) Patient unresponsive to initial therapy MELASMA A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen B Pharmacological therapy Dual Combination erapy • Hydroquinone plus • Tretinoin or • Azelaic acid Responding to Yes Continue treatment treatment? as required No A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen • Laser therapy • Dermabrasion B Pharmacological therapy Triple Combination erapy • Hydroquinone plus • Tretinoin plus • Topical steroid Chemical peels 1 MELASMA • Acquired hyperpigmentary skin disorder characterized by irregular light to dark brown macules occurring in the sun-exposed areas of the face, neck & arms - Occurs most commonly w/ pregnancy (chloasma) & w/ the use of contraceptive pills - Other factors implicated in the etiopathogenesis are photosensitizing medications, genetic factors, mild ovarian or thyroid dysfunction, & certain cosmetics • Most commonly aff ects Fitzpatrick skin phototypes III & IV • More common in women than in men • Rare before puberty & common in women during their reproductive years • Solar & ©ultraviolet exposure is the mostMIMS important factor in its development Not all products are available or approved for above use in all countries.
    [Show full text]
  • Frequency of Different Types of Facial Melanoses Referring to the Department of Dermatology and Venereology, Nepal Medical Colle
    Amatya et al. BMC Dermatology (2020) 20:4 https://doi.org/10.1186/s12895-020-00100-3 RESEARCH ARTICLE Open Access Frequency of different types of facial melanoses referring to the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital in 2019, and assessment of their effect on health-related quality of life Bibush Amatya* , Anil Kumar Jha and Shristi Shrestha Abstract Background: Abnormalities of facial pigmentation, or facial melanoses, are a common presenting complaint in Nepal and are the result of a diverse range of conditions. Objectives: The objective of this study was to determine the frequency, underlying cause and impact on quality of life of facial pigmentary disorders among patients visiting the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital (NMCTH) over the course of one year. Methods: This was a cross-sectional study conducted at the Department of Dermatology and Venereology, NMCT H. We recruited patients with facial melanoses above 16 years of age who presented to the outpatient department. Clinical and demographic data were collected and all the enrolled participants completed the validated Nepali version of the Dermatology Life Quality Index (DLQI). Results: Between January 5, 2019 to January 4, 2020, a total of 485 patients were recruited in the study. The most common diagnoses were melasma (166 patients) and post acne hyperpigmentation (71 patients). Quality of life impairment was highest in patients having melasma with steroid induced rosacea-like dermatitis (DLQI = 13.54 ± 1.30), while it was lowest in participants with ephelides (2.45 ± 1.23). Conclusion: Facial melanoses are a common presenting complaint and lead to substantial impacts on quality of life.
    [Show full text]
  • Breastfeeding Contraindications
    WIC Policy & Procedures Manual POLICY: NED: 06.00.00 Page 1 of 1 Subject: Breastfeeding Contraindications Effective Date: October 1, 2019 Revised from: October 1, 2015 Policy: There are very few medical reasons when a mother should not breastfeed. Identify contraindications that may exist for the participant. Breastfeeding is contraindicated when: • The infant is diagnosed with classic galactosemia, a rare genetic metabolic disorder. • Mother has tested positive for HIV (Human Immunodeficiency Syndrome) or has Acquired Immune Deficiency Syndrome (AIDS). • The mother has tested positive for human T-cell Lymphotropic Virus type I or type II (HTLV-1/2). • The mother is using illicit street drugs, such as PCP (phencyclidine) or cocaine (exception: narcotic-dependent mothers who are enrolled in a supervised methadone program and have a negative screening for HIV and other illicit drugs can breastfeed). • The mother has suspected or confirmed Ebola virus disease. Breastfeeding may be temporarily contraindicated when: • The mother is infected with untreated brucellosis. • The mother has an active herpes simplex virus (HSV) infection with lesions on the breast. • The mother is undergoing diagnostic imaging with radiopharmaceuticals. • The mother is taking certain medications or illicit drugs. Note: mothers should be provided breastfeeding support and a breast pump, when appropriate, and may resume breastfeeding after consulting with their health care provider to determine when and if their breast milk is safe for their infant and should be provided with lactation support to establish and maintain milk supply. Direct breastfeeding may be temporarily contraindicated and the mother should be temporarily isolated from her infant(s) but expressed breast milk can be fed to the infant(s) when: • The mother has untreated, active Tuberculosis (TB) (may resume breastfeeding once she has been treated approximately for two weeks and is documented to be no longer contagious).
    [Show full text]
  • Skin Care, Hair Care and Cosmetic Treatments in Pregnancy and Breastfeeding
    Skin Care, Hair Care and Cosmetic Treatments in Pregnancy and Breastfeeding Information in this leaflet is general in nature and should not take the place of advice from your health care provider. With every pregnancy there is a 3 to 5% risk of having a baby with a birth defect. Issues for pregnancy Many pregnant women have skin and hair concerns just as they did before pregnancy. Sometimes conditions such as acne actually worsen during pregnancy because of hormonal changes and often women notice darkening of their skin (melasma). However, due to concern about potentially hazardous exposures to their unborn babies, pregnant women are often uncertain about which products are safe for them to use. Generally cosmetic treatments are discretionary (not medically necessary) and if safety is uncertain, women should consider whether the product or treatment is really required. There are several considerations when evaluating whether a specific skin or hair product is unsafe in pregnancy. Firstly, the active ingredient in the product needs to be considered unsafe. Secondly, it also has to be able to reach the unborn baby in its mother’s womb by inhalation or absorption through the mother’s skin (topical application). Although there is often limited information about the actual safety of specific ingredients in skin products during pregnancy, if it is known that skin absorption is minimal then the exposure to the unborn baby is generally insignificant and the product or treatment is regarded as safe. Below is a summary of current advice. Cosmetics, Moisturisers and other Skin Care Products Cosmetics and over the counter skin products generally contain ingredients that are unlikely to be harmful in pregnancy as they are used by applying to the skin (rather than swallowing a tablet).
    [Show full text]
  • A New Insight on Atopic Skin Diathesis: Is It Correlated with the Severity of Melasma
    A New Insight on Atopic Skin Diathesis: Is It Correlated with the Severity of Melasma Danar Wicaksono1*, Rima Mustafa2, Sri Awalia Febriana1, Kristiana Etnawati1 1 Dermatovenereology Department, Faculty of Medicine Universitas Gadjah Mada – Dr. Sardjito General Hospital, Yogyakarta-Indonesia 2 Clinical Epidemiology and Biostatistics Unit, Faculty of Medicine Universitas Gadjah Mada –Dr. Sardjito General Hospital, Yogyakarta-Indonesia Keywords: Melasma, atopic skin diathesis (ASD), MASI score, atopic dermatitis (AD) Abstract: Melasma is a macular lesion of light brown to dark on the sun-exposed area, especially on the face. Atopic Skin Diathesis (ASD) is a clinical term to describe skin atopics with previous, present or future atopic dermatitis (AD). Dennie-Morgan infraorbital folds are secondary creases in the skin below the lower eyelids with a sensitivity of 78% and a specificity of 76% to diagnose AD. Melasma skin is characterized by impaired stratum corneum integrity and a delayed barrier recovery rate. Barrier dysfunction will stimulate keratinocyte to secrete keratinocyte-derived factor, which plays role in skin pigmentation process in melasma. To analyze correlation between ASD and Melasma Area Severity Index (MASI) score in melasma patient. This study is an observational analytic study with cross sectional design. Measurement of ASD and MASI score were done in 60 subjects with melasma who went to dermatology outpatient clinic Dr. Sardjito General Hospital from July 2017 to Januari 2018. The correlation between ASD and MASI score was analyzed using Pearson correlation. The result of this study showed no significant correlation between ASD and MASI scores (r: 0.02, p: 0,85). Crude Relative Risk (RR) for Dennie-Morgan infraorbital folds and MASI score was 4 (1.01-15.87).
    [Show full text]
  • 00005721-201907000-00003.Pdf
    2.0 ANCC Contact Hours Angela Y. Stanley, DNP, APRN-BC, PHCNS-BC, NEA-BC, RNC-OB, C-EFM, Catherine O. Durham, DNP, FNP-BC, James J. Sterrett, PharmD, BCPS, CDE, and Jerrol B. Wallace, DNP, MSN, CRNA SAFETY OF Over-the-Counter MEDICATIONS IN PREGNANCY Abstract Approximately 90% of pregnant women use medications while they are pregnant including both over-the-counter (OTC) and prescription medications. Some medica- tions can pose a threat to the pregnant woman and fetus with 10% of all birth defects directly linked to medications taken during pregnancy. Many medications have docu- mented safety for use during pregnancy, but research is limited due to ethical concerns of exposing the fetus to potential risks. Much of the information gleaned about safety in pregnancy is collected from registries, case studies and reports, animal studies, and outcomes management of pregnant women. Common OTC categories of readily accessible medications include antipyretics, analgesics, nonsteroidal anti- infl ammatory drugs, nasal topicals, antihistamines, decongestants, expectorants, antacids, antidiar- rheal, and topical dermatological medications. We review the safety categories for medications related to pregnancy and provide an overview of OTC medications a pregnant woman may consider for management of common conditions. Key words: Pharmacology; Pregnancy; Safety; Self-medication. Shutterstock 196 volume 44 | number 4 July/August 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. he increased prevalence of pregnant women identifi ed risks in animal-reproduction studies or completed taking medications, including over-the-counter animal studies show no harm. The assignment of Category (OTC) medications presents a challenge to C has two indications; (1) limited or no research has been nurses providing care to women of childbear- conducted about use in pregnancy, and (2) animal studies ing age.
    [Show full text]
  • Breastfeeding Matters
    Breastfeeding Matters An important guide for breastfeeding families ACKNOWLEDGEMENTS Best Start by Health Nexus would like to thank the Public Health Units of Ontario who supported the creation and development of this provincial resource and generously shared their resources and expertise. We would also like to thank the parents and the experts who provided input for this booklet. Final review was done by Marg La Salle, RN, BScN, IBCLC, and BFI Lead Assessor. The information in this booklet is current at the time of production but information can change over time. Every effort will be made to ensure the information remains current. Throughout this resource, gender-specific language such as “woman”, “women” and “mother” is used in order to accurately cite the research referred to. We intend these terms to refer to all childbearing individuals, regardless of their gender identity or sexual orientation. Funded by the Government of Ontario. Table of Contents SECTION 1 .......................... 3 SECTION 4 ........................ 27 The Importance of Breastfeeding Important Things to Know • Risks of Not Breastfeeding • Waking a Sleepy Baby • Your Breastfeeding Rights • Calming a Fussy Baby • The Baby-Friendly Initiative • Burping Your Baby • Making an Informed Decision • Growth Spurts • Family Support • Sore Nipples • Peer Support • Using a Pacifier (Soother) • Engorgement SECTION 2 ........................ 11 • Storing Your Breast Milk Helping Your Baby Get a Good Start • Skin-to-Skin SECTION 5 ........................ 33 • Safe Positioning
    [Show full text]
  • In a New Video, the Mom of Two Reveals the Dark Spot Toner She Swears By
    In a new video, the mom of two reveals the dark spot toner she swears by. Hilary Duff, who is mom to Luca, 7, and Banks, 1, recently shared her “busy mom makeup routine” with Vogue — including the product she uses to treat her pregnancy melasma. “I’m a busy mom,” the actress says in the video. “I don’t have a ton of time to do my makeup, but this version today is on a day when I have my kids but also have a couple of meetings and I want to look like I put some effort in.” Duff starts off her routine by washing her hands or using hand sanitizer. She then reaches for her toner. “One really ‘cool’ thing that happened to me when I had babies is I got melasma,” she shared, pointing to a dark spot near the top of her forehead. “Every day, I say a little prayer that it’s taking care of that dark spot right there,” she says, rubbing on Ole Henriksen’s Glow2OH Dark Spot Toner ($29; sephora.com). Other products in Duff's kit include REN Clean Skincare Keep Young and Beautiful Anti-Aging Eye Cream ($44; sephora.com) and Perricone MD No Makeup Foundation Broad Spectrum SPF 20 ($60; ulta.com). What is melasma, exactly? Melasma is a common skin condition that causes brown to gray-brown patches to develop, usually on the face. Also referred to as the mask of pregnancy, melasma appears when a sharp rise in estrogen and progesterone levels stimulates excess melanin production, also known as hyperpigmentation.
    [Show full text]
  • Iris Mammillations: Significance and Associations
    IRIS MAMMILLATIONS: SIGNIFICANCE AND ASSOCIATIONS 2 l NICOLA K. RAGGEL2, 1. ACHESON and A. LINN MURPHREE Los Angeles and London SUMMARY mammiform (nipple- or teat-like) protuberances. Iris mammillations are rarely described, distinctive Iris mammillations are an occasional finding with few previous reports. They are most commonly villiform protuberances that can cover the iris. In the l--6 majority of reported cases they are unilateral and found in association with melanosis oculi, with or sporadic, and are seen in association with oculodermal without periocular skin involvement in a naevus of melanosis. In past literature and current clinical Ota. They are thus often less precisely referred to as practice they are frequently confused with tbe iris iris melanosis, a term which should best be reserved nodules seen in neurofibromatosis type 1. Their clinical for increased pigmentation of the iris, irrespective of significance is not established, although it has been the presence of iris elevations overlying the pigmen­ 7 suggested that iris mammillations may be an external ted areas. This is supported by the rare descriptions sign of ocular hypertension or intraocular malignancy. of iris elevations in the absence of any increased iris We report a series of 9 patients between the ages of 3 pigmentation?,8 and 28 years with iris mammillations. The mammilla­ Iris mammillations are usually unilateral, often tions appear as regularly spaced, deep brown, smooth, presenting as heterochromia iridis. Occasional bilat­ 7 conical elevations on the iris, of uniform height or eral cases have been described. ,8 Iris mammillations increasing in height as the pupil margin is approached.
    [Show full text]